Promotion of the mind through exercise (PROMoTE): a proof-of-concept randomized controlled trial of aerobic exercise training in older adults with vascular cognitive impairment
- PMID: 20158920
- PMCID: PMC2830197
- DOI: 10.1186/1471-2377-10-14
Promotion of the mind through exercise (PROMoTE): a proof-of-concept randomized controlled trial of aerobic exercise training in older adults with vascular cognitive impairment
Abstract
Background: Sub-cortical vascular ischaemia is the second most common etiology contributing to cognitive impairment in older adults, and is frequently under-diagnosed and under-treated. Although evidence is mounting that exercise has benefits for cognitive function among seniors, very few randomized controlled trials of exercise have been conducted in populations at high-risk for progression to dementia. Aerobic-based exercise training may be of specific benefit in delaying the progression of cognitive decline among seniors with vascular cognitive impairment by reducing key vascular risk factors associated with metabolic syndrome. Thus, we aim to carry out a proof-of-concept single-blinded randomized controlled trial primarily designed to provide preliminary evidence of efficacy aerobic-based exercise training program on cognitive and everyday function among older adults with mild sub-cortical ischaemic vascular cognitive impairment.
Methods/design: A proof-of-concept single-blinded randomized trial comparing a six-month, thrice-weekly, aerobic-based exercise training group with usual care on cognitive and everyday function. Seventy older adults who meet the diagnostic criteria for sub-cortical ischaemic vascular cognitive impairment as outlined by Erkinjuntti and colleagues will be recruited from a memory clinic of a metropolitan hospital. The aerobic-based exercise training will last for 6 months. Participants will be followed for an additional six months after the cessation of exercise training.
Discussion: This research will be an important first step in quantifying the effect of an exercise intervention on cognitive and daily function among seniors with sub-cortical ischaemic vascular cognitive impairment, a recognized risk state for progression to dementia. Exercise has the potential to be an effective, inexpensive, and accessible intervention strategy with minimal adverse effects. Reducing the rate of cognitive decline among seniors with sub-cortical ischaemic vascular cognitive impairment could preserve independent functioning and health related quality of life in this population. This, in turn, could lead to reduced health care resource utilization costs and avoidance of early institutional care.
Trial registration: ClinicalTrials.gov NCT01027858.
Figures
Similar articles
-
Aerobic exercise and vascular cognitive impairment: A randomized controlled trial.Neurology. 2016 Nov 15;87(20):2082-2090. doi: 10.1212/WNL.0000000000003332. Epub 2016 Oct 19. Neurology. 2016. PMID: 27760869 Free PMC article. Clinical Trial.
-
Synergistic effects of aerobic exercise and cognitive training on cognition, physiological markers, daily function, and quality of life in stroke survivors with cognitive decline: study protocol for a randomized controlled trial.Trials. 2017 Aug 31;18(1):405. doi: 10.1186/s13063-017-2153-7. Trials. 2017. PMID: 28859664 Free PMC article. Clinical Trial.
-
Efficacy and mechanisms of combined aerobic exercise and cognitive training in mild cognitive impairment: study protocol of the ACT trial.Trials. 2018 Dec 22;19(1):700. doi: 10.1186/s13063-018-3054-0. Trials. 2018. PMID: 30577848 Free PMC article.
-
Physical exercise as a preventive or disease-modifying treatment of dementia and brain aging.Mayo Clin Proc. 2011 Sep;86(9):876-84. doi: 10.4065/mcp.2011.0252. Mayo Clin Proc. 2011. PMID: 21878600 Free PMC article. Review.
-
Cognitive training for persons with mild cognitive impairment.Int Psychogeriatr. 2008 Feb;20(1):57-66. doi: 10.1017/S104161020700631X. Epub 2007 Oct 25. Int Psychogeriatr. 2008. PMID: 17958927 Review.
Cited by
-
Physical activity program for patients with dementia and their relative caregivers: randomized clinical trial in Primary Health Care (AFISDEMyF study).BMC Neurol. 2014 Apr 1;14:63. doi: 10.1186/1471-2377-14-63. BMC Neurol. 2014. PMID: 24684948 Free PMC article. Clinical Trial.
-
Body mass index, lifestyles, physical performance and cognitive decline: the "Treviso Longeva (TRELONG)" study.J Nutr Health Aging. 2013 Apr;17(4):378-84. doi: 10.1007/s12603-012-0397-1. J Nutr Health Aging. 2013. PMID: 23538662
-
Agreement between Patient and Proxy Assessments of Quality of Life among Older Adults with Vascular Cognitive Impairment Using the EQ-5D-3L and ICECAP-O.PLoS One. 2016 Apr 21;11(4):e0153878. doi: 10.1371/journal.pone.0153878. eCollection 2016. PLoS One. 2016. PMID: 27101402 Free PMC article. Clinical Trial.
-
Aerobic exercise and vascular cognitive impairment: A randomized controlled trial.Neurology. 2016 Nov 15;87(20):2082-2090. doi: 10.1212/WNL.0000000000003332. Epub 2016 Oct 19. Neurology. 2016. PMID: 27760869 Free PMC article. Clinical Trial.
-
Treatment of vascular dementia. Recommendations of the Scientific Department of Cognitive Neurology and Aging of the Brazilian Academy of Neurology.Dement Neuropsychol. 2011 Oct-Dec;5(4):275-287. doi: 10.1590/S1980-57642011DN05040005. Dement Neuropsychol. 2011. PMID: 29213754 Free PMC article. Review.
References
-
- Rockwood K, Wentzel C, Hachinski V, Hogan DB, MacKnight C, McDowell I. Prevalence and outcomes of vascular cognitive impairment. Vascular Cognitive Impairment Investigators of the Canadian Study of Health and Aging. Neurology. 2000;54(2):447–451. - PubMed
-
- Desmond DW, Erkinjuntti T, Sano M, Cummings JL, Bowler JV, Pasquier F, Moroney JT, Ferris SH, Stern Y, Sachdev PS. The cognitive syndrome of vascular dementia: implications for clinical trials. Alzheimer disease and associated disorders. 1999;13(Suppl 3):S21–29. - PubMed
-
- Erkinjuntti T, Bowler JV, DeCarli CS, Fazekas F, Inzitari D, O'Brien JT, Pantoni L, Rockwood K, Scheltens P, Wahlund LO. Imaging of static brain lesions in vascular dementia: implications for clinical trials. Alzheimer disease and associated disorders. 1999;13(Suppl 3):S81–90. - PubMed
-
- Pantoni L, Leys D, Fazekas F, Longstreth WT Jr, Inzitari D, Wallin A, Filippi M, Scheltens P, Erkinjuntti T, Hachinski V. Role of white matter lesions in cognitive impairment of vascular origin. Alzheimer disease and associated disorders. 1999;13(Suppl 3):S49–54. - PubMed
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Medical